![]() |
|
|
Vol. 295, Issue 3, 1232-1240, December 2000
Departments of Pharmacology (G.D.S., I.L., P.M.) and Psychiatry
(I.L.), and Institute for Neurological Sciences (G.D.S., I.L., P.M.),
University of Pennsylvania School of Medicine, Philadelphia,
Pennsylvania
Regulation of the expression of dopamine D2 and D3 receptors in the rat
brain was examined using quantitative autoradiography after chronic (14 day) drug treatments designed to increase or decrease dopamine receptor
stimulation. Reserpine treatment depleted endogenous dopamine by more
than 90% and significantly increased the binding of
[125I]NCQ 298 to D2 receptors in the nucleus accumbens,
ventral pallidum, and substantia nigra. In contrast, this treatment
significantly decreased the binding of [125I]7-OH-PIPAT
to D3 receptors in each of these regions. Chronic stimulation of
D2-like receptors with quinpirole (1 mg/kg/day) or 7-OH-DPAT (1 mg/kg/day) produced decreases in [125I]NCQ 298 binding in
the nucleus accumbens, ventral pallidum, and substantia nigra as
expected. As with depletion, chronic stimulation elicited an opposite
response from D3 receptors with significant increases observed in the
ventral pallidum and substantia nigra. D3 receptor expression in the
nucleus accumbens was unchanged. Baclofen (30 mg/kg/day) or continuous
administration of the psychomotor stimulant cocaine (20 mg/kg/day)
produced no significant changes in D2 or D3 receptor binding in any
region examined. Acute administration of the irreversible antagonist
EEDQ (10 mg/kg) nearly eliminated D2 receptor binding in all regions,
but inactivated D3 receptors only in the VP and SN, suggesting
subtype-specific and region-specific differences in receptor occupancy.
The existence of regional and subtype-specific heterogeneities in the
regulation of these receptors supports the contention that despite
their similar pharmacological profiles, D2 and D3 receptors may mediate
different functional responses.
This article has been cited by other articles:
![]() |
D. D. Kline, G. Hendricks, G. Hermann, R. C. Rogers, and D. L. Kunze Dopamine Inhibits N-Type Channels in Visceral Afferents to Reduce Synaptic Transmitter Release Under Normoxic and Chronic Intermittent Hypoxic Conditions J Neurophysiol, May 1, 2009; 101(5): 2270 - 2278. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cervenka, S. E. Palhagen, R. A. Comley, G. Panagiotidis, Z. Cselenyi, J. C. Matthews, R. Y. Lai, C. Halldin, and L. Farde Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding Brain, August 1, 2006; 129(8): 2017 - 2028. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Stanwood, R. P. Artymyshyn, M.-P. Kung, H. F. Kung, I. Lucki, and P. McGonigle Quantitative Autoradiographic Mapping of Rat Brain Dopamine D3 Binding with [125I]7-OH-PIPAT: Evidence for the Presence of D3 Receptors on Dopaminergic and Nondopaminergic Cell Bodies and Terminals J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1223 - 1231. [Abstract] [Full Text] |
||||